Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Alergia e Inmunología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
INTERVENTIONAL
Inicio: 26 de jul de 2011
ID: NCT01384734
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis
INTERVENTIONAL
Inicio: 31 de jul de 2025
ID: NCT07044297
Desconocido
ClinicalTrials.gov
A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires
OBSERVATIONAL
Inicio: 11 de sept de 2023
ID: NCT05919277
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Controlled, Open-label Trial to Compare the Efficacy, Safety and Tolerability of TMC114/RTV Versus LPV/RTV in Treatment-Experienced HIV-1 Infected Patients
INTERVENTIONAL
Inicio: 1 de abr de 2005
ID: NCT00110877
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomised, Double-blind, Multicentre, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Dolutegravir Plus Lamivudine Compared to Dolutegravir Plus Tenofovir/Emtricitabine in HIV-1-infected Treatment-naïve Adults
INTERVENTIONAL
Inicio: 18 de jul de 2016
ID: NCT02831764
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Placebo-controlled, Dose-ranging, Multi-centre Trial of QAW039 (1-450 mg p.o.), to Investigate the Effect on FEV1 and ACQ in Patients With Moderate-to-severe, Persistent, Allergic Asthma, Inadequately Controlled With ICS Therapy.
INTERVENTIONAL
Inicio: 1 de ago de 2011
ID: NCT01437735
Completado
Fase 3
ClinicalTrials.gov
Phase III Randomized Trial of the Safety and Efficacy of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV-1 Transmission
INTERVENTIONAL
Inicio: 1 de feb de 2004
ID: NCT00099359
Reclutando
ClinicalTrials.gov
A Prospective, Observational Study to Assess the Real-World Usage and Outcomes of HyQvia in Patients With Multiple Myeloma (MM) Diagnosed With Secondary Immunodeficiency (SID)
OBSERVATIONAL
Inicio: 17 de oct de 2023
ID: NCT05879757
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab Monotherapy for the First-line Treatment of Patients With PD-L1-high Metastatic Non-small Cell Lung Cancer (ARTEMIDE-Lung04)
INTERVENTIONAL
Inicio: 10 de abr de 2025
ID: NCT06868277
Completado
Fase 2
ClinicalTrials.gov
A Phase 2a, Randomized, Double-Blind (Sponsor Unblinded), Placebo-Controlled, Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH4524184 in HIV-1 Infected Treatment Naïve Adults
INTERVENTIONAL
Inicio: 7 de feb de 2024
ID: NCT06214052
Completado
Fase 1
ClinicalTrials.gov
Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.
INTERVENTIONAL
Inicio: 1 de sept de 2014
ID: NCT02583464
Completado
Fase 3
ClinicalTrials.gov
A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine Once Daily Compared to Atazanavir and Ritonavir Plus Tenofovir/Emtricitabine Once Daily in HIV-1 Infected Antiretroviral Therapy Naïve Women
INTERVENTIONAL
Inicio: 22 de ago de 2013
ID: NCT01910402
Completado
Fase 3
ClinicalTrials.gov
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
INTERVENTIONAL
Inicio: 15 de dic de 2015
ID: NCT02549170
Completado
Fase 3
ClinicalTrials.gov
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of QAW039 When Added to Existing Asthma Therapy in Patients With Uncontrolled Severe Asthma.
INTERVENTIONAL
Inicio: 11 de dic de 2015
ID: NCT02555683
Completado
Fase 2
ClinicalTrials.gov
A 48 Week, Phase II, Open-label, 2-cohort, Multicenter Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Antiviral Activity of GW433908 and GW433908/RTV When Administered to HIV-1 Infected Protease Inhibitor (PI) Naive and PI-experienced Pediatric Subjects Aged 4 Weeks to <2 Years.
INTERVENTIONAL
Inicio: 23 de oct de 2003
ID: NCT00071760
Completado
ClinicalTrials.gov
Positive Connections: COPA2
INTERVENTIONAL
Inicio: 1 de jul de 2016
ID: NCT02846350
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre 24-week Study to Evaluate the Efficacy and Safety of Mepolizumab Adjunctive Therapy in Subjects With Severe Eosinophilic Asthma on Markers of Asthma Control
INTERVENTIONAL
Inicio: 11 de dic de 2014
ID: NCT02281318
Completado
Fase 3
ClinicalTrials.gov
An Evaluation of Bone Mineral Density in HIV-1-infected Adult Subjects Switching From a Tenofovir-containing Antiretroviral Therapy Regimen to a Dolutegravir Plus Rilpivirine Regimen
INTERVENTIONAL
Inicio: 12 de jun de 2015
ID: NCT02478632
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
INTERVENTIONAL
Inicio: 12 de ago de 2020
ID: NCT04428333
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blind Trial of TMC278 25 mg q.d. Versus Efavirenz 600mg q.d. in Combination With a Fixed Background Regimen Consisting of Tenofovir Disoproxil Fumarate and Emtricitabine in Antiretroviral-naive HIV-1 Infected Subjects.
INTERVENTIONAL
Inicio: 1 de may de 2008
ID: NCT00540449
Anterior
1
...
3
4
5
...
434
Siguiente
Filtros